1,157 filings
Page 43 of 58
424B3
qbm2xu7 w9
13 Oct 09
Prospectus supplement
12:00am
8-K
bwmkithiryr1j
30 Sep 09
Discovery Labs and FDA Establish Path for Potential SURFAXIN Approval
12:00am
424B3
vant030dg6ix2qoxg
24 Sep 09
Prospectus supplement
12:00am
8-K
2o23 r24ly
11 Sep 09
Other Events
12:00am
8-K
hqh tvukwedjfu5v
4 Sep 09
Discovery Labs Announces Date of 2009 Annual Shareholder Meeting
12:00am
8-K
1vfu94o2na7n 5rl3r
19 Aug 09
Discovery Labs Announces Resignation of CEO Robert J. Capetola, Ph.D.; W. Thomas Amick, Chairman of the Board, Appointed Interim CEO
12:00am
8-K
1nyln1sq0
3 Aug 09
Discovery Labs Provides Second Quarter 2009 Financial Results and Business Strategy Update
12:00am
8-K
tninjf7328cup
2 Jul 09
Discovery Labs Reports on Surfaxin End of Review Meeting with FDA
12:00am
8-K
ttpvy
15 May 09
Discovery Labs Announces Completion of $11.3 Million Registered Direct Offering
12:00am
8-K
3h6gabsg5fy
12 May 09
Other Events
12:00am
424B3
ed06qwn9v0itf9ooul
12 May 09
Prospectus supplement
12:00am
424B5
9yodvs
8 May 09
Prospectus supplement for primary offering
12:00am
8-K
2tftcwng4ist2ofmzh8
8 May 09
Discovery Labs to Raise $11.3 Million in Registered Direct Offering
12:00am
8-K
11ugrvn2t5
29 Apr 09
Discovery Labs Reports First Quarter 2009 Financial Results
12:00am
8-K
by7z43zj hr
24 Apr 09
Discovery Labs Receives Complete Response from FDA
12:00am
424B3
skg wprci
9 Apr 09
Prospectus supplement
12:00am